Skip to main content
Article
ELISA Measurement of Specific Non-antigen-bound Antibodies to Ab1-42 Monomer and Soluble Oligomers in Sera from Alzheimer's Disease, Mild Cognitively Impaired, and Noncognitively Impaired Subjects
Journal of Neuroinflammation
  • Andrea C. Klaver
  • Mary P. Coffey
  • Lynnae M. Smith
  • David A. Bennett
  • John M. Finke, University of Washington Tacoma
  • Loan Dang
  • David A. Loeffler
Publication Date
1-1-2011
Document Type
Article
Abstract

The article presents a study for enzyme-linked immunosorbent assay (ELISA) measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in Alzheimer's disease (AD), mild cognitively impaired (MCI), and noncognitively impaired (NCI) sera. In the study, serum samples were obtained from the Rush Alzheimer's Disease Center, Chicago, Illinois.

DOI
10.1186/1742-2094-8-93
Version
pre-print, post-print, pub PDF
Citation Information
Andrea C. Klaver, Mary P. Coffey, Lynnae M. Smith, David A. Bennett, et al.. "ELISA Measurement of Specific Non-antigen-bound Antibodies to Ab1-42 Monomer and Soluble Oligomers in Sera from Alzheimer's Disease, Mild Cognitively Impaired, and Noncognitively Impaired Subjects" Journal of Neuroinflammation Vol. 8 Iss. 1 (2011) p. 93
Available at: http://works.bepress.com/john_finke/7/